EIT Health

Trak is a company that specializes in developing software for tele-rehabilitation, aimed at healthcare professionals. Its platform enables the prescription of therapeutic exercises to patients while monitoring their treatment progress. Utilizing the camera capabilities of cell phones, tablets, or laptops, Trak's software can assess patients' movements in real time, providing corrective feedback on their exercise execution. This technology empowers healthcare providers to deliver high-quality digital rehabilitation services, such as physiotherapy, enhancing patient care and engagement in their recovery process.

Noah Labs develops innovative technology aimed at the early detection of cardiovascular diseases through voice analysis. Utilizing advanced machine learning software, the company has created a digital health platform that allows patients to record their voices using a smartphone. This platform incorporates patient monitoring and digital biomarkers, providing personalized and predictive virtual care in the comfort of their homes. By focusing on voice-based diagnostics, Noah Labs seeks to empower individuals with cardiovascular conditions to lead healthier and longer lives.

Idoven is a pioneering company that has created the world’s first cardiology-as-a-service platform utilizing artificial intelligence to enhance the capabilities of both cardiologists and non-cardiology clinicians in identifying, triaging, and diagnosing patients on a large scale. The company's innovative software analyzes prolonged electrocardiograms to detect early signs of heart problems, including alterations in cardiac electrical activity and arrhythmias, thereby facilitating timely diagnoses and preventing serious conditions such as myocardial infarction and sudden cardiac death. Idoven has established partnerships with prominent organizations, including AstraZeneca, Abbott, and GE Healthcare, and has gained recognition in the healthcare sector, receiving multiple awards for its AI technology from notable institutions in Europe and the United States. The company has also been recognized as one of the top 50 companies in Digital Health for 2023 by CB Insights.

eBreathie is an innovative digital health startup focused on enhancing asthma management through its integrated solution. The company has developed a smart inhaler that tracks not only the timing of medication usage but also the technique employed by patients, generating detailed inhalation profiles. This device is complemented by a user-friendly mobile application for patients and a comprehensive management platform for healthcare providers. By utilizing Internet of Things (IoT) technology and artificial intelligence (AI), eBreathie's system delivers real-time feedback on inhalation efficacy, empowering both patients and doctors with critical insights for effective asthma care. The company's mission is to minimize emergency visits, asthma attacks, and hospitalizations while promoting effective inhalation techniques and optimal patient outcomes.

Ochre Bio Ltd is a biotechnology company focused on developing genomic medicines specifically for transplanted livers and the treatment of fatty liver conditions. Founded in 2019 and based in Headington, United Kingdom, the company employs advanced genomic techniques to identify and inhibit overactive genes associated with liver diseases. This approach includes testing therapies in discarded donor livers that are maintained outside the body, ensuring that potential treatments can be evaluated in a relevant biological context. With over 15 years of expertise in liver genomics research, Ochre Bio aims to create a pipeline of innovative medicines that address liver and liver-mediated conditions, ultimately enhancing the availability of healthy livers for transplantation and reducing complications associated with cirrhosis. The company operates within Oxford's biotechnology innovation hub, leveraging its scientific foundation to advance therapeutic solutions in the field of liver health.

Nanordica Medical is an Estonian medical technology company specializing in advanced wound care solutions. The company has developed a patented nanotechnology that combines copper and silver in nanofibers to effectively remove infections and promote healing in chronic wounds. Nanordica Medical has launched a veterinary product, Ravimus Vet, designed for treating animal wounds, while also focusing on a first-in-class wound dressing for challenging human conditions, such as diabetic foot ulcers. Recent clinical trials have demonstrated that their wound dressing outperforms traditional silver ion-based dressings across multiple efficacy parameters, offering a more powerful antibacterial effect that can inactivate a wider range of bacteria, including drug-resistant strains.

ZiO Health is a biotechnology company focused on enhancing patient outcomes through its innovative pocket-sized laboratory testing technology. The company has developed proprietary biosensor devices that utilize machine learning algorithms to provide real-time results tailored to individual patient profiles. These multi-functional electronic devices are designed for measuring, testing, and detecting the molecular composition of various chemical and biological substances, enabling users to assess the presence, absence, or quantity of specific target molecules. By delivering quality home diagnostics and personalized testing solutions, ZiO Health aims to empower individuals to optimize their health and prevent illness.

OptiChroniX is a Swiss-based digital health solutions company focused on enhancing brain health through early intervention. The company specializes in developing digital therapeutics that integrate biomedical, behavioral, computing, and engineering research. These interventions are deployed on smartphones and utilize data from wearable devices to personalize and monitor patients' health progress. OptiChroniX aims to improve clinical outcomes, quality of life, and cost-effectiveness by providing tailored coaching to enhance health literacy, medication adherence, and address modifiable risk factors associated with cognitive decline in conditions like Alzheimer’s disease and related comorbidities.

Onward Assist is a healthcare technology company specializing in advanced cancer prognostics. The company develops a predictive analytics platform that enhances the accuracy and efficiency of cancer diagnosis and pathology reporting. Utilizing machine learning and computer vision, Onward Assist provides automated diagnostic tools and treatment decision support tailored for oncologists, pathologists, and radiologists. Its flagship product, PathAssist, integrates an AI layer with tools for automated diagnostics in histopathology, a telepathology solution, and affordable slide digitization hardware. By analyzing and predicting the behavior of cancer cells, Onward Assist aims to improve treatment outcomes and ensure that healthcare professionals can make informed decisions based on deeper insights into tumors and surrounding tissues.

PKvitality is a bio-wearable company based in Paris, France, that specializes in innovative health monitoring solutions. Founded in 2017, the company has developed K’Track, a line of trackers that assess key physiological markers through skin analysis, eliminating the need for blood samples. Its flagship product, K’Watch Glucose, is a continuous glucose monitoring device designed in the form of a smartwatch, featuring a micro-needle sensor that allows diabetics to monitor their glucose levels painlessly and discreetly. The device provides real-time alerts through on-body vibrations for hypo or hyperglycemic episodes, enhancing user convenience and safety. In addition to glucose monitoring, PKvitality is expanding its offerings to include continuous lactate monitoring and multi-analyte monitors, further advancing the field of wearable health technology.

Dotlumen is a research startup founded in 2020 and based in Cluj, Romania, focused on enhancing the quality of life for visually impaired individuals. The company develops innovative glasses equipped with a sensory and feedback system that aids users in navigating their environments. By leveraging advancements in artificial intelligence, robotics, and neuroscience, Dotlumen aims to empower blind individuals to better understand and interact with the world around them.

Dotlumen is a research startup founded in 2020 and based in Cluj, Romania, focused on enhancing the quality of life for visually impaired individuals. The company develops innovative glasses equipped with a sensory and feedback system that aids users in navigating their environments. By leveraging advancements in artificial intelligence, robotics, and neuroscience, Dotlumen aims to empower blind individuals to better understand and interact with the world around them.

NovaBleep is an innovative communications infrastructure layer specifically designed for hospitals. Various modular components are included to replace communication streams such as pagers, referral systems, fault reporting systems, concern escalation systems, ward chats etc. By streamlining and digitalising these essential communication processes, NovaBleep revolutionises the way hospitals operate. The flow of a patient from entering an ED to discharge/death represents the flow of data. Not all of this data is yet digitalised. Data will be aggregated using NovaBleep for use in Machine Learning to predict the trajectory of patients, and to potentially predict mortality.

Orbit Health specializes in developing an artificial intelligence-driven solution for personalized treatment of Parkinson's disease. Their platform uses smartwatch motion data to continuously monitor motor symptoms, providing objective insights to enable physicians to tailor treatments for optimal patient outcomes.

Apneal is a healthcare technology company that specializes in sleep diagnostics. It has developed a mobile application designed to diagnose sleep apnea by utilizing a smartphone's built-in sensors, such as microphones, accelerometers, and gyroscopes, to monitor patients' sleep patterns. The app operates in airplane mode, ensuring it does not emit or receive electromagnetic waves during use. By employing deep learning algorithms, Apneal transforms smartphones into medical devices capable of automatically detecting cardio-respiratory events and analyzing sleep quality through interpretable signals. The results of these assessments are then presented to healthcare providers on an ergonomic dashboard, allowing for timely evaluations without the need for cumbersome equipment or extended waiting periods.

Lymphatica Medtech SA is a Swiss company that specializes in the design and manufacture of medical devices aimed at treating lymphatic diseases, particularly lymphedema. Founded in 2017 and based in Lausanne, the company has developed innovative solutions such as the LymphoDrain system, which includes an active implantable lymphatic bypass that integrates a magnetically controlled micropump and subcutaneous catheters. This technology is designed to re-establish lymphatic circulation by internally draining lymphatic fluid from multiple points in the affected limb, providing a minimally invasive remedy for patients suffering from lymphedema. Lymphatica Medtech's commitment to advancing treatment options in this field reflects its focus on improving patient outcomes through cutting-edge medical technology.

Radiobotics is a technology company focused on developing advanced machine learning algorithms that assist healthcare professionals in analyzing medical images, particularly x-rays of bones and joints. By automating routine tasks and generating radiology reports, the company's solutions facilitate quicker access to critical diagnostic information, thereby enhancing the quality of medical decision-making. Radiobotics aims to support doctors by streamlining the image analysis process, ultimately contributing to improved patient outcomes through more accurate and timely diagnoses.

Tympany Medical is a company focused on advancing minimally invasive ear surgeries through innovative technology. It has developed a specialized ear surgery device that facilitates sterile endoscopy in the field of otolaryngology. This device addresses the challenges associated with traditional endoscopes, enhancing usability and flexibility for surgeons. By enabling effective endoscopic visualization, Tympany's technology allows surgeons to perform complex ear procedures while preserving their two-handed operating technique. The company's mission is to reduce the need for unnecessary mastoidectomies and improve surgical outcomes for patients undergoing ear surgery.

Biel Glasses, SL is a company based in Barcelona, Spain, established in 2017, that specializes in the development and sale of electronic smart glasses aimed at enhancing mobility and personal autonomy for individuals with low vision. The innovative glasses integrate 3D vision and artificial intelligence algorithms to detect obstacles, changes in terrain, and street crossings, adapting to varying light conditions. Additionally, they feature zoom and image enhancement capabilities, providing a comprehensive solution that empowers users to navigate their environments safely and independently, ultimately improving their quality of life.

Ilya Pharma AB, established in 2016 and headquartered in Uppsala, Sweden, specializes in developing biological drugs for treating skin and mucosal wounds. The company's innovative approach involves genetically modifying lactic acid bacteria, commonly found in yogurt, to produce substances that accelerate wound healing. Ilya Pharma focuses on both acute and chronic wounds, with a particular emphasis on addressing the unique challenges faced by diabetic patients.

Allcyte is a biotech start-up specializing in functional drug testing using primary human materials. The company has developed a high-content imaging platform known as Pharmacoscopy, which incorporates AI-supported image analysis to assess drug effects at the single-cell level. This technology closely simulates in vivo conditions, allowing for a realistic preview of drug efficacy in actual patients. Allcyte's mission is to advance personalized medicine for cancer treatment by providing physicians and pharmaceutical companies with critical insights to prioritize the most suitable drugs for specific indications. By minimizing sample manipulation and employing sophisticated statistical and machine learning techniques, Allcyte aims to enhance biomedical decision-making and optimize cancer treatment outcomes.

Hemotune AG is a medical device company based in Zürich, Switzerland, founded in 2016. The company specializes in developing a therapeutic blood purification platform that utilizes magnetic blood purification technology to address infections and other health ailments. Hemotune's innovative approach involves the use of magnetic beads, which facilitate the selective and efficient removal of large biomolecules from the bloodstream. This technology focuses on the immunological aspects of conditions like sepsis, allowing for targeted treatment that addresses multiple disease pathways. By enhancing the purification of blood in acute care settings, Hemotune aims to improve patient outcomes for those suffering from blood-related diseases.

Oxford Endovascular is focused on developing an innovative biotechnology device aimed at treating brain aneurysms. The company's technology employs a laser-cut metal alloy that utilizes shape-memory properties, enabling it to be inserted into a patient's brain via a catheter. Once in place, the device expands into a small mesh tube, commonly referred to as a flow diverter, which conforms to the natural shape of the blood vessel. This design effectively diverts blood flow away from the aneurysm, promoting healing and reducing the risk of rupture. By utilizing advanced engineering techniques, Oxford Endovascular aims to enhance patient outcomes and improve survival rates for individuals affected by this serious condition.

Orthox Ltd. is a medical implant company based in Abingdon, United Kingdom, that specializes in developing tissue regenerative implants for knee cartilage injuries. Founded to commercialize technology from Oxford University, Orthox aims to transform the treatment of cartilage damage, addressing the needs of over 300 million patients worldwide affected by osteoarthritis. The company's flagship product, FibroFix, is a hydrogel implant designed to emulate human knee cartilage, enabling effective repair and regeneration of damaged tissues. Orthox offers several variations of FibroFix, including FibroFix Meniscus for meniscal cartilage repair and FibroFix Cartilage for articular cartilage damage. The implants promote integration with the body's cells, facilitating a return to active, pain-free living. With plans to expand its technology to other joints and additional applications beyond orthopaedics, Orthox is positioned to capitalize on the rapidly growing biomaterials market, projected to exceed $250 billion by 2025.

HT BioImaging Ltd. is an innovative company specializing in medical imaging technology focused on the early detection of oral cancer. Founded in 2015 and headquartered in Ganei Am, Israel, the company has developed the HTOScan, a device that utilizes heat diffusion imaging combined with artificial intelligence to analyze tissue. This technology measures the heat diffusion and dissipation within the examined tissue, producing images that indicate the likelihood of cancer. HT BioImaging aims to provide a non-invasive, real-time diagnostic tool for clinicians, allowing for the detection and classification of cancerous tissues directly in community clinics and operating rooms. The company’s team consists of experts in AI, signal analysis, computer vision, and oncology, working together to advance cancer detection methods.

Portabiles HealthCare Technologies specializes in developing advanced solutions for medical gait analysis. The company offers a system that tracks patients with chronic diseases, utilizing a validated high-end algorithm to deliver clinical-grade gait parameters. This technology allows therapists to access critical information related to patients' daily activities through a telehealth platform or smartphones. By providing clinically relevant data, Portabiles enables healthcare professionals to modify and optimize therapy regimes, ultimately enhancing patient care and outcomes.

Volumina Medical SA is a Swiss company specializing in the development, manufacturing, and commercialization of advanced tissue reconstruction technologies tailored for the reconstructive and plastic surgery markets. The company focuses on tissue engineering, creating injectable 3D scaffolds that facilitate the reconstruction of lost soft tissue volumes due to tumor ablation, disease, trauma, or aesthetic needs. These innovative scaffolds can be administered through thin cannulas, which helps reduce both intervention and recovery times for patients, addressing the challenges associated with the natural repair of three-dimensional soft tissues.

Mowoot is a company that specializes in developing wearable medical devices aimed at improving the quality of life for individuals suffering from chronic constipation. Founded in 2014 and based in Barcelona, Spain, Mowoot offers a non-pharmacological and non-invasive solution that simulates a manual abdominal massage performed by healthcare professionals. Utilizing advanced pneumatic technology, its device provides automatic colon-specific massages to stimulate intestinal transit, thereby helping to treat and prevent chronic slow transit constipation without the need for colon cleansing supplements, enemas, or laxatives. Mowoot emerged from the MOEBIO dHEALTH program, drawing inspiration from concepts in design and business innovation.

MRIguidance is a medical imaging company established in 2016 as a spin-off from UMC Utrecht. Founded by MR physicist Peter Seevinck, image scientist Marijn van Stralen, and entrepreneur Roel Raatgever, the company specializes in the development of BoneMRI, a proprietary imaging technique that enhances the analysis of magnetic resonance imaging data. MRIguidance's software allows for 3D visualization of bone anatomy using standard MRI scanners, enabling medical practitioners to assess all human tissues in a single examination without the exposure to harmful radiation. This innovative approach positions MRIguidance as a comprehensive solution in the field of medical imaging.

Neurent Medical Limited is a medical device company based in Galway, Ireland, founded in 2015 by Brian Shields and David Townley. The company specializes in developing non-surgical treatments for inflammatory sino-nasal diseases, specifically focusing on chronic rhinitis. Neurent Medical offers a single-use, minimally invasive device designed for ENT surgeons, which utilizes a hand-held radio-frequency mechanism. This device is introduced through the nostrils into the nasal cavity under direct endoscopic visualization, where it deploys a microelectrode array to deliver targeted energy. This intervention interrupts the autonomic function of the mucosal structures in the nasal cavities, effectively reversing the inflammatory cascade. By enabling treatment in an office setting, Neurent Medical aims to eliminate the complications and costs typically associated with traditional surgical procedures for rhinitis.

Ancora.ai is an AI-driven platform designed to enhance clinical trial recruitment by connecting patients and healthcare professionals to relevant trials in under five minutes. The company employs a proprietary matching technology that prioritizes a patient-first approach, aiming to democratize access to clinical trials and accelerate recruitment processes. Ancora.ai specifically focuses on providing cancer patients with tailored treatment options and personalized clinical trial matches, while ensuring data privacy. Through its innovative platform, Ancora.ai facilitates broader access to clinical research as a viable care alternative, ultimately improving patient outcomes and advancing medical research.

Paragit Solutions specializes in developing innovative systems for remote patient monitoring and data-driven clinical management of movement disorders, particularly Parkinson's disease. Central to their offerings is the Paragit Sleeve, which employs a patented sEMG (electromyography) technology to gather precise data on muscle activation, movement, and grip force during patients' daily activities. Paragit provides two main software suites for data interpretation: the PD Monitor, tailored for caregivers, which visualizes key motor symptoms like rigidity and tremors to enhance treatment optimization and facilitate telemedicine; and the MD Lab, designed for decentralized clinical trials across various movement disorders. MD Lab enables researchers to analyze over 20 metrics related to disease severity, track trends, and compare groups consistently, with a robust API that supports extensive data access for further analysis. Through these technologies, Paragit aims to improve the management and understanding of movement disorders, enhancing patient care and clinical research.

BOCAhealth is a patented portable device (connected to an app) that is able to measure and keep track of the hydration status of a user without the need for medical personnel.

SCARLETRED is an international digital health company transforming the skincare sector through its innovative SCARLETRED®VISION platform. This AI-powered system addresses the challenges of subjective skin assessment and the lack of standardization in dermatology. The platform, which is certified as a medical device, operates via a mobile app on smartphones and connects to a web platform to generate smart imaging data and support decision-making in dermatology and telemedicine. SCARLETRED's technology, protected by worldwide patents, facilitates standardized skin documentation and allows for remote tracking of skin changes and therapeutic effects. Users can upload images to a cloud-based platform for objective analysis of visual skin changes over time, including allergic reactions, pigmentation variations, acne, psoriasis, and wound healing. The company's services cater to a wide range of dermatological conditions and are provided to the biopharma and cosmetics industries, as well as hospitals and medical experts, through a SaaS model.

Vitrue Health specializes in digital technology aimed at reducing musculoskeletal issues through accurate measurement and assessment. The company's flagship products, including VIDA and Vitrue EVVA, utilize advanced computer vision and biomechanics to objectively evaluate musculoskeletal health in various settings, from workplaces to clinical environments. VIDA specifically addresses the needs of desk workers by assessing their workspaces and ensuring compliance with ergonomic standards, helping to mitigate common problems like back and neck pain. Vitrue EVVA employs depth sensors for clinical-grade evaluations, which are valuable in orthopaedics, injury prevention in elite sports, and health screenings. By providing detailed reports and predictive insights regarding functional ability and core strength, Vitrue Health empowers both clinicians and patients to identify issues early, design optimal treatment plans, and engage patients in their recovery. The company’s mission is to establish a new foundation for musculoskeletal healthcare, aiming to alleviate pain and improve the quality of life for millions.

Pharma Latch, a division of Latch Medical, specializes in innovative drug and vaccine delivery systems, focusing on intradermal administration. The company has developed a unique tissue anchor system that employs micro-needle technology, featuring angled microneedles designed to painlessly penetrate the outer layers of the skin. This method not only enhances the patient experience but also ensures consistent needle penetration for effective delivery. By leveraging its core platform technology, Pharma Latch provides healthcare professionals with improved alternatives to traditional wound stitching, unlocking the potential of various drugs and vaccines in a more efficient manner.

WaytoB is a company that specializes in developing innovative navigation solutions aimed at enhancing the mobility of individuals with special educational needs. Their flagship product is a wearable device that utilizes assistive technology to deliver intuitive, icon-based directions, helping users navigate outdoor environments safely and independently. The application also provides critical safety information, such as safe crossing points, while allowing family members to monitor the user's location, heart rate, and battery life. By focusing on accessibility, WaytoB aims to empower individuals with higher support needs, enabling them to travel with confidence and providing peace of mind to their loved ones.

AquAffirm is a company focused on developing innovative technological solutions for critical global issues related to water quality and public health. It creates a user-friendly web-based tool that employs advanced models for analyzing epidemic trajectories and managing health restrictions, particularly in the context of COVID-19. In addition to this, AquAffirm designs digital sensors capable of measuring harmful water contaminants, such as arsenic and fluoride. These devices integrate sophisticated mapping and infrastructure modeling capabilities, offering real-time optimization tools that generate detailed three-dimensional models of water infrastructure. This comprehensive approach enables clients, including small businesses and developing nations, to effectively address significant biomedical and environmental challenges.

BeneTalk is a digital speech therapy application designed to assist individuals who stutter in improving their communication skills. The app functions as an on-demand speech-tracking tool that monitors breathing and speech patterns, offering real-time feedback and performance history tracking. This innovative approach allows users to learn and practice new speaking habits in a variety of speaking situations, much like a fitness tracker for speech. By empowering users and their families, BeneTalk aims to enhance the quality of life for those facing speech and language challenges.

Novus Diagnostics is focused on developing an innovative diagnostic device aimed at detecting sepsis. This technology allows for the rapid and automated identification of pathogens present in whole blood samples. By providing results in minutes, Novus Diagnostics empowers healthcare providers to initiate effective treatment for sepsis patients quickly and efficiently. The approach not only enhances patient care but also aims to reduce costs associated with sepsis management.

UFraction8 is a developer of innovative bioprocessing technology that specializes in scalable solutions for biomass filtration, separation, and dewatering. The company’s technology is applicable to a diverse range of microorganisms, including microalgae, yeast, and bacteria, allowing for the effective sorting of biomass from culture media without the use of harmful flocculants or traditional methods such as centrifugation and membrane filtration. By utilizing advanced microfluidic devices, uFraction8 enhances throughput for industrial-scale applications, including liquid particle processing and selective concentration of pathogens. This technology offers a cost-effective alternative to conventional liquid processing methods, enabling industries to improve efficiency and reduce expenses in their operations.

NeoMimix is a biotechnology company focused on enhancing assisted human reproduction through its innovative sperm selection technology. The firm has developed a microfluidics platform combined with a disposable chip component that mimics the natural environment of the female reproductive tract. This advanced system enables the sorting and selection of high-quality, low-DNA fragmented sperm, which is crucial for improving reproductive outcomes. The process is designed to be simple and fully traceable, ensuring reliability and efficiency in sperm selection. By utilizing biomimicry, NeoMimix aims to provide a more natural approach to sperm selection, ultimately contributing to better results in fertility treatments.

Hygiene Audits specializes in developing software solutions aimed at enhancing infection prevention and control within nursing homes and healthcare facilities. The company's software provides automated workflows for care staff, enabling them to efficiently track and manage infection risks. By offering digital audit tools, Hygiene Audits ensures compliance with national standards and facilitates the monitoring of environmental hygiene practices. The primary objective of the software is to reduce healthcare-associated infections, thereby improving the safety and well-being of both patients and staff in healthcare settings.

CapBuster is a developer of a medical device designed to address the challenges of penetrating blocked arteries, particularly in cases involving calcified occlusions. The company's innovative balloon catheter and guidewire combination device employs a mechanical screw-thread mechanism, allowing physicians to effectively re-open resistant blockages using standard angioplasty tools and techniques. This solution not only facilitates a faster and more efficient procedure but also enhances safety and efficacy, requiring minimal training for medical practitioners. CapBuster's device is noted for its cost-effectiveness and low-risk profile, making it an accessible option for hospitals without the need for additional capital equipment.

Oxolife is a biotechnology startup established in January 2013, dedicated to research and development in reproductive efficiency and infertility treatments. Founded by a multidisciplinary team of biochemists and clinical pharmacologists with over a decade of experience in the pharmaceutical market, Oxolife focuses on improving female fertility. The company's innovative drug targets the endometrium to enhance embryo implantation and restore ovulation. By streamlining the infertility treatment process, Oxolife aims to provide clinicians with effective solutions for assisting infertile women and couples.

KroniKare AI-based system helps with early detection of complications such as infection, undermining and blood circulation problems. This can significantly reduce costs for chronic wound care from faster recovery of patients to productivity gains and upskilling of junior nurses.

BioXplor, Inc. is a research and development company founded in 2017 and based in Berkeley, California. It operates an augmented intelligence platform that focuses on data-driven hypotheses generation and novel predictions in biomarker and drug discovery. The company leverages big data, artificial intelligence, and high-performance computing to enhance the interpretation of unstructured literature and structured multi-omics data. BioXplor's projects, both in-house and external, are concentrated on AI-assisted biomarker discovery, molecular target identification, and drug repurposing, with a particular emphasis on cancer and rare diseases.

Vinehealth is a technology company that develops a patient-centric digital application aimed at enhancing oncology patient outcomes. By integrating behavioral science and artificial intelligence, its platform provides personalized support to cancer patients, allowing them to effectively track, manage, and understand their care. The application generates valuable patient-reported data, which informs health service delivery, drug development, and research. This approach enables clinicians to offer tailored services based on a comprehensive understanding of patient experiences, ultimately improving the overall quality of cancer care.

CrannMed is a medical company focused on addressing the challenges of knee osteoarthritis, a condition that causes chronic pain and limits mobility for many patients. The company develops innovative bioresorbable embolic particles and a specialized balloon occlusion microcatheter, providing a minimally invasive alternative treatment option. By offering these advanced solutions, CrannMed aims to improve patient outcomes and halt disease progression, positioning itself in the growing particle embolization market. Through its efforts, the company seeks to enhance the quality of life for individuals suffering from this debilitating condition.

Upstream Health is a company based in North Lincolnshire, United Kingdom, that specializes in developing innovative technologies and service approaches for health and social care teams. Founded in 2018, the company utilizes artificial intelligence alongside a mobile and analytics platform to promote a proactive, "upstream" approach to healthcare, focusing on preventive care. Upstream Health's platform is designed to enhance electronic medical record systems, enabling health and social care professionals to improve patient outcomes through comprehensive clinical functions. By integrating experienced technologists and health service innovators, Upstream Health aims to address the evolving needs of the health and social care systems, ultimately improving citizen health outcomes.

SurgiQ is an AI-driven healthcare technology company dedicated to optimizing hospital operations through advanced planning and scheduling solutions. Specializing in surgical procedures, chemotherapy, and rehabilitation, SurgiQ enables healthcare institutions to streamline workflows, reduce patient waiting times, and enhance resource efficiency. The company's patented technology focuses on balancing workloads and improving patient care while also contributing to better financial performance for hospitals. Serving both public and private healthcare facilities, SurgiQ provides a scalable and impactful solution that delivers measurable results. The company is experiencing significant growth, doubling its year-over-year performance and positioning itself for further international expansion.

Oncochain is focused on developing a real-world data platform specifically for oncology, aimed at standardizing and aggregating anonymized data from cancer patients. This platform facilitates the generation of valuable analytics that support research initiatives for pharmaceutical companies and enhance value-based care for healthcare providers. Utilizing a proprietary web-based electronic health record system tailored for oncology, Oncochain creates operational data repositories that streamline the flow of information between providers and improve the skills of oncology professionals. The company significantly contributes to research by reducing recruitment times for clinical trials and establishing frameworks for multi-centric study design and implementation. Through its software-as-a-service analytics tool, Oncochain delivers essential real-world data insights to clients, including cancer centers, clinicians, and life sciences organizations, thereby accelerating research and optimizing treatment outcomes.

I'm Fine is a technology company specializing in mental health support. It operates a mobile application and web platform that provides users with psychological resources and tools to better understand and manage their emotions. The platform offers personalized mood recommendations, referrals to vetted psychotherapists, and progress tracking features. It also facilitates therapy sessions, psychometric tests, and online payments, aiming to improve therapeutic outcomes for users.

Biel Glasses, SL is a company based in Barcelona, Spain, established in 2017, that specializes in the development and sale of electronic smart glasses aimed at enhancing mobility and personal autonomy for individuals with low vision. The innovative glasses integrate 3D vision and artificial intelligence algorithms to detect obstacles, changes in terrain, and street crossings, adapting to varying light conditions. Additionally, they feature zoom and image enhancement capabilities, providing a comprehensive solution that empowers users to navigate their environments safely and independently, ultimately improving their quality of life.

SentinHealth is a life science company specializing in integrated care solutions designed to monitor and prevent the deterioration of chronic illnesses, particularly heart failure. The company develops advanced telemonitoring technology that includes an implant connected to the cloud, providing daily health status updates and predictive insights. This system focuses on early detection of acute decompensated heart failure (ADHF) by monitoring daily heart activity and other indicators from the digestive system, allowing for timely interventions before hospitalization becomes necessary. SentinHealth addresses the critical needs of patients requiring continuous automated monitoring, ultimately aiming to enhance patient outcomes in the management of serious chronic conditions.

ABLE Human Motion is a Barcelona-based medical device start-up founded in 2018, focused on developing robotic exoskeletons to enhance mobility for individuals with disabilities. The company’s flagship product, the ABLE Exoskeleton, is a lightweight and user-friendly wearable device designed to assist paraplegic individuals in standing, walking, and sitting down. This innovative technology incorporates a motor and gearbox that mimic muscle function, along with inertial sensors that detect the user's intentions. By enabling greater mobility and independence, the ABLE Exoskeleton aims to improve the quality of life for its users while also serving as a rehabilitation tool for clinicians, enhancing the efficiency of therapy and promoting daily ambulation within the community.

Menutech is a B2B SaaS company revolutionizing the foodservice industry through AI-driven menu planning personalization. It caters to F&B managers, dieticians, and nursing staff in hospitals, senior homes, and hospitality businesses. Menutech's platform automates the creation of personalized meal plans tailored to individual dietary needs, reducing health risks and overprocurement costs by up to 90%.

Sleepiz AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in manufacturing a non-contact sleep disorder-screening device. The product monitors breathing, heart rate, and body movements with medical-grade accuracy using wireless millimeter wave technology, sensor fusion, and artificial intelligence. This device is designed to be placed on the bedside table for easy use, enabling healthcare professionals to monitor patients' sleep patterns from home. Sleepiz aims to facilitate long-term monitoring of chronic diseases, allowing for faster intervention and improved treatment outcomes.

Pipra is a MedTech startup focused on developing innovative tools aimed at preventing, predicting, and diagnosing delirium, particularly postoperative delirium, which significantly affects older patients and incurs substantial costs for healthcare systems. The company offers an AI-driven clinical decision support software designed to help healthcare professionals identify patients at high risk of developing postoperative delirium prior to surgery. The tool utilizes standard medical data and delivers a risk assessment in under two minutes through a web or app-based platform. This capability allows medical staff to tailor operative plans and implement clinical interventions, ultimately reducing the incidence of postoperative delirium by up to 53%. Currently, Pipra's technology is operational in three hospitals, with plans to expand to 22 additional facilities across Europe. The company's advisory board includes notable experts from prestigious institutions such as Johns Hopkins, Harvard, and Cornell, further underscoring its commitment to addressing this critical healthcare issue.

iLoF, or Intelligent Lab on Fiber, is a technology company specializing in the integration of photonics and artificial intelligence to enhance drug discovery and development. The company has developed a patented system that identifies and captures unique features of gold-standard biomarkers, creating a cloud-based digital library of these biological profiles. This platform allows for the collection of extensive data, which facilitates personalized medicine by enabling healthcare companies to conduct more efficient and patient-centric clinical trials. By employing a multidisciplinary approach that involves physicists, biologists, and data scientists, iLoF aims to accelerate the development of tailored treatments, ultimately improving patient outcomes and reducing the costs associated with drug development.

The Oxford Foundry is an entrepreneurial growth center located within the University of Oxford, established in 2017. It serves as an accelerator firm dedicated to supporting venture creation and growth while harnessing talent to address global challenges. The Foundry offers a variety of resources, including masterclasses, access to a network of industry experts, mentors, and advisors, as well as grant funding. Additionally, it provides assistance with legal and financial guidance and offers co-working space through its accelerator program.

TeiaCare is a health technology company focused on enhancing the long-term care sector through the use of artificial intelligence. The company has developed ANCELIA, an advanced AI solution that automatically collects and analyzes data on the conditions of residents in care homes. This technology empowers healthcare workers and managers by improving daily assistance activities and allowing for the delivery of higher quality care to a greater number of residents without additional effort. By leveraging data, TeiaCare provides valuable insights and reports that optimize decision-making and management processes within nursing homes. The company emphasizes a new care model based on personalized assistance, objective data, and transparency, aiming to address inefficiencies in monitoring post-acute hospital patients and ensuring better outcomes for residents.

Be Sure Healthcare is a digital health company that specializes in remote patient monitoring and clinical decision support. It uses data from wearable devices, IoT, and medical equipment, along with external data, to analyze key health indicators in real-time. This enables the company to predict and mitigate emergent situations, optimize health plans, and improve patient outcomes. Be Sure Healthcare has a specific focus on supporting healthcare providers with COVID-19 patients through its Precise COVID19 platform, offering remote monitoring and clinical decision support.

Sleepiz AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in manufacturing a non-contact sleep disorder-screening device. The product monitors breathing, heart rate, and body movements with medical-grade accuracy using wireless millimeter wave technology, sensor fusion, and artificial intelligence. This device is designed to be placed on the bedside table for easy use, enabling healthcare professionals to monitor patients' sleep patterns from home. Sleepiz aims to facilitate long-term monitoring of chronic diseases, allowing for faster intervention and improved treatment outcomes.

Smiletronix is a company focused on transforming dental care through its innovative home dental check-up and teledentistry solutions. Utilizing a patented intra-oral imaging device and an accompanying application, Smiletronix enables users to perform comprehensive dental health scans for issues such as cavities and gum disease in under a minute, all from the comfort of their homes. This approach promotes preventive care by allowing individuals to monitor their dental health regularly and connect conveniently with clinicians. By emphasizing proactive dental management, Smiletronix aims to reduce the pain and costs associated with reactive dental treatments, ultimately making dental care more accessible and efficient for all users.

BrachyDOSE is a medical technology company specializing in a quality control tool for cancer radiotherapy treatment. Their innovative solution combines a flexible, disposable radiation dose measurement sensor with deep learning algorithms to provide accurate, real-time data. This empowers oncologists to minimize side effects, optimize treatment efficacy, and enhance patient recovery, potentially reducing overall treatment costs by 3-5 times. The solution consists of a radiation dose measurement sensor, a data retrieval scanner, and an injury prediction algorithm for decision support. BrachyDOSE aims to improve patient outcomes and streamline treatment processes in over 2000 hospitals worldwide.

Ergobyte Informatics S.A. is a software development company based in Thessaloniki, Greece, established in 2002 by George Nikolaidis. The company specializes in custom application development and offers a range of commercial products and services. Ergobyte conducts research in various areas of information and communication technology, including computer-aided diagnosis, knowledge representation, machine learning, and data analytics. It develops off-the-shelf software products and information systems tailored to the needs of the medical sector, notably creating Galen, an extensive online drug database focused on human pharmacology. Additionally, Ergobyte designs applications for mobile platforms, supporting both iPhone and Android devices, thereby enhancing accessibility in healthcare and related fields. The company emphasizes collaboration with clients to develop customized solutions that improve operational efficiency and foster business growth.

Biel Glasses, SL is a company based in Barcelona, Spain, established in 2017, that specializes in the development and sale of electronic smart glasses aimed at enhancing mobility and personal autonomy for individuals with low vision. The innovative glasses integrate 3D vision and artificial intelligence algorithms to detect obstacles, changes in terrain, and street crossings, adapting to varying light conditions. Additionally, they feature zoom and image enhancement capabilities, providing a comprehensive solution that empowers users to navigate their environments safely and independently, ultimately improving their quality of life.

Sleepiz AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in manufacturing a non-contact sleep disorder-screening device. The product monitors breathing, heart rate, and body movements with medical-grade accuracy using wireless millimeter wave technology, sensor fusion, and artificial intelligence. This device is designed to be placed on the bedside table for easy use, enabling healthcare professionals to monitor patients' sleep patterns from home. Sleepiz aims to facilitate long-term monitoring of chronic diseases, allowing for faster intervention and improved treatment outcomes.

Elypta AB is a molecular diagnostic company based in Stockholm, Sweden, founded in 2017. The company is focused on developing a metabolism-based liquid biopsy platform that aids in the early detection and monitoring of cancer. This platform employs a novel in vitro diagnostic laboratory assay kit and artificial intelligence algorithms, which analyze biomarkers in blood and urine to identify cancer signatures. Elypta's technology offers comprehensive profiling of glycosaminoglycan metabolites and includes scoring software to support a wide range of cancer applications, from screening to treatment response monitoring. The company is currently conducting clinical trials, particularly the AURORAX series, to investigate its platform's efficacy in renal cell carcinoma and other cancer indications, aiming to reduce cancer mortality through timely intervention.

TeiaCare is a health technology company focused on enhancing the long-term care sector through the use of artificial intelligence. The company has developed ANCELIA, an advanced AI solution that automatically collects and analyzes data on the conditions of residents in care homes. This technology empowers healthcare workers and managers by improving daily assistance activities and allowing for the delivery of higher quality care to a greater number of residents without additional effort. By leveraging data, TeiaCare provides valuable insights and reports that optimize decision-making and management processes within nursing homes. The company emphasizes a new care model based on personalized assistance, objective data, and transparency, aiming to address inefficiencies in monitoring post-acute hospital patients and ensuring better outcomes for residents.

ABLE Human Motion is a Barcelona-based medical device start-up founded in 2018, focused on developing robotic exoskeletons to enhance mobility for individuals with disabilities. The company’s flagship product, the ABLE Exoskeleton, is a lightweight and user-friendly wearable device designed to assist paraplegic individuals in standing, walking, and sitting down. This innovative technology incorporates a motor and gearbox that mimic muscle function, along with inertial sensors that detect the user's intentions. By enabling greater mobility and independence, the ABLE Exoskeleton aims to improve the quality of life for its users while also serving as a rehabilitation tool for clinicians, enhancing the efficiency of therapy and promoting daily ambulation within the community.

Abtrace is a provider of AI-driven solutions designed to enhance medical expertise and improve patient care. The company focuses on developing clinical decision-making tools that transform the detection, monitoring, and treatment of chronic and long-term health conditions. By leveraging machine learning and big data techniques, Abtrace's software analyzes patient data to provide actionable insights for healthcare professionals. This technology helps general practitioners and healthcare assistants make informed decisions, automate disease monitoring, and recognize early clinical signs of new conditions. As a result, Abtrace aims to eliminate duplication, improve patient safety, reduce the misuse of antibiotics, and lower practice costs, ultimately leading to better treatment outcomes in real time.

RemAb Therapeutics specializes in the development of polymeric glycoconjugate molecules aimed at addressing nosocomial infections. The company's innovative technology focuses on eliminating non-neutralizing natural antibodies that hinder the immune system's natural response and promote pathogen proliferation. By targeting these antibodies, RemAb Therapeutics seeks to provide medical practitioners with effective new strategies for both treating and preventing a range of pathological infections, enhancing patient outcomes in the process.

SensArs is a medical equipment manufacturing company specializing in neuromodulation for diabetic neuropathy. The company's flagship product, SENSY, is a healthcare technology system designed to restore natural sensations in the feet of patients suffering from amputation or nerve damage. SensArs has developed a patented implantable neurostimulator electrode that delivers targeted electrical impulses to the nerve fibers responsible for transmitting pain signals. This innovative approach enables healthcare professionals to enhance patient functionality and provides a long-term solution for pain management. Through its advancements in neurostimulation technology, SensArs aims to improve the quality of life for individuals affected by sensory loss.

STENTiT is a medical device company that originated as a spin-off from the Eindhoven University of Technology in the Netherlands. The company specializes in the development of regenerative endovascular implants, specifically biodegradable stents designed to restore arteries. STENTiT's innovative products aim to trigger a natural healing response in patients, allowing blood cells to replace the implant with new vascular tissue. This approach enables medical professionals to effectively treat patients suffering from cardiovascular diseases by promoting internal restoration of the affected arteries.

Nanoleq AG is a Swiss company founded in 2017 and based in Zurich, specializing in the development and manufacture of electric cables utilizing stretchable electronics. As a spinoff from ETH Zurich, Nanoleq focuses on integrating electronic functionality into textiles, particularly for health monitoring. The company creates soft sensors that can track vital signs such as heart rate, electrocardiograms, and breathing patterns through washable and comfortable garments. Their innovative conductive silicone technology allows for the monitoring of various physiological parameters while maintaining user comfort. Nanoleq aims to establish a standard for health-monitoring textiles, making significant strides in sectors such as healthcare, robotics, aerospace, and general electronics, while also working on further advancements in textile sensor technology.

Sleepiz AG, founded in 2018 and headquartered in Zurich, Switzerland, specializes in manufacturing a non-contact sleep disorder-screening device. The product monitors breathing, heart rate, and body movements with medical-grade accuracy using wireless millimeter wave technology, sensor fusion, and artificial intelligence. This device is designed to be placed on the bedside table for easy use, enabling healthcare professionals to monitor patients' sleep patterns from home. Sleepiz aims to facilitate long-term monitoring of chronic diseases, allowing for faster intervention and improved treatment outcomes.

TeiaCare is a health technology company focused on enhancing the long-term care sector through the use of artificial intelligence. The company has developed ANCELIA, an advanced AI solution that automatically collects and analyzes data on the conditions of residents in care homes. This technology empowers healthcare workers and managers by improving daily assistance activities and allowing for the delivery of higher quality care to a greater number of residents without additional effort. By leveraging data, TeiaCare provides valuable insights and reports that optimize decision-making and management processes within nursing homes. The company emphasizes a new care model based on personalized assistance, objective data, and transparency, aiming to address inefficiencies in monitoring post-acute hospital patients and ensuring better outcomes for residents.

Biel Glasses, SL is a company based in Barcelona, Spain, established in 2017, that specializes in the development and sale of electronic smart glasses aimed at enhancing mobility and personal autonomy for individuals with low vision. The innovative glasses integrate 3D vision and artificial intelligence algorithms to detect obstacles, changes in terrain, and street crossings, adapting to varying light conditions. Additionally, they feature zoom and image enhancement capabilities, providing a comprehensive solution that empowers users to navigate their environments safely and independently, ultimately improving their quality of life.

GlyCardial Diagnostics S.L. is a biotechnology company based in Barcelona, Spain, established in 2017 as a spin-off from the Catalan Institute of Cardiovascular Sciences and the Spanish National Research Council. The company specializes in developing point-of-care diagnostic devices aimed at detecting abnormal levels of the Apo J-Glyc protein in blood, serving as a biomarker for the early diagnosis of myocardial ischemia. GlyCardial's innovative technology seeks to identify patients at risk of experiencing ischemic attacks before they occur, addressing significant unmet medical needs in cardiovascular care. By facilitating timely healthcare decisions, the company's solutions aim to reduce the risk of irreversible myocardial damage and heart failure, ultimately improving patient outcomes following ischemic events.

Delox is a Portuguese company focused on the design and development of bio-decontamination devices aimed at creating clean and biosafe environments. Founded in 2018 as a spin-off from the Faculty of Sciences of the University of Lisbon, Delox specializes in automatic bio-decontamination robots and has developed a proprietary solid formulation of hydrogen peroxide, known as DeloxHP. This innovation allows for the efficient production of compact and cost-effective bio-decontamination devices, including the Delox Box, which is ready for market use. The company’s technology is applicable in various sectors, including the sterilization of medical devices, room bio-decontamination in hospitals and the food industry, as well as the decontamination of laboratory equipment and environmental test chambers. Delox aims to provide non-toxic solutions that effectively combat microorganisms, catering to the health, pharmaceutical, biodefense, and space industries.

Adelie Health is an app that helps people with diabetes manage their insulin doses.

Inovus Medical is a company that specializes in designing and manufacturing medical simulation products, primarily aimed at enhancing surgical training. Founded in 2012 and based in Saint Helens, United Kingdom, Inovus produces a range of simulators, including take-home and institutional laparoscopic simulators, which facilitate the training of surgical trainees and residents. Their products cover essential procedures such as laparoscopic appendectomy and cholecystectomy, as well as training tools for critical care and general medicine. By providing accessible and versatile healthcare training equipment, Inovus Medical aims to improve surgical skills and, consequently, the quality of patient care. The company serves its customers through online platforms, making its training solutions widely available.

We develop a new PET scanner technology that reduces costs significantly, enabling a wider use of PET by research, training and diagnostic imaging centers. Our mission is to increase access to PET imaging around the world, by providing uniquely affordable, high resolution compact systems. Our motto: keep PET simple!

Onalabs develops remote, continuous and non-invasive bio-medical devices to monitor through the skin and sweat several vital signs and some biomarkers. Onalabs is the first non-invasive device able to measure some chemical parameters present in sweat using miniaturised biosensors. Its non-invasive products based on wearable formats empower the patients and their families to measure relevant vital signs and biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier management strategies, resulting in shorter hospital stays and prevention of unnecessary treatments. The solutions are addressed to chronic patients, such as COPD, HF and Diabetes.

Climedo, founded in Munich in 2017, is a leading provider of an all-in-one electronic Clinical Outcome Assessment (eCOA) and Electronic Data Capture (EDC) solution, designed for non-interventional studies and real-world evidence. The company focuses on patient-centric research by offering a platform that enables real-time data insights and visualizations, enhancing engagement between healthcare professionals and key opinion leaders. This approach facilitates scientific dialogue and accelerates the successful launch of medical innovations, ultimately reaching more patients efficiently. With over 1.7 million patients enrolled, Climedo serves a diverse clientele, including pharmaceutical companies, medical technology firms, contract research organizations, and academic institutions, by providing fully digitalized medical research data that supports informed clinical decision-making and product validation.

We believe that good care is not a privilege. That is why we have developed intelligent solutions under the nevisCura brand that significantly improve the living and working situation of people in the care sector. Our technical assistance systems have been specially developed for care facilities to offer them a cost-effective and efficient solution for more relief and security. In doing so, we have never lost sight of the customer focus and have incorporated the feedback from numerous pilot projects with long-standing customers into the further development. Only in this way could we be sure that our solutions supported caregivers in their everyday work and relieved them in the long term. And that for many years: because the solutions are designed to be future-proof so that you benefit from regular updates and the highest level of investment protection. Our solution consists of the nevisCura bed and room sensor. The bed sensor from nevisCura is an intelligent bed exit alarm that noticeably facilitates the daily work of caregivers. Once attached to the bed in just a few steps, the silent guard discreetly signals when a resident wants to get out of bed - even before he or she has set foot on the floor. And best of all: the sensor is compatible with every common call system. The room sensor from nevisCura is an innovative sensor system that is used for fall detection and prevention in outpatient and inpatient care facilities. Once installed all around at the height of the base boards, it offers the greatest protection for residents and noticeably relieves caregivers.

Oxford Heartbeat is a developer of medical device software focused on improving the planning and execution of cardiovascular surgeries. The company offers a healthcare platform that provides surgeons with critical insights into real patient blood vessels, enabling them to visualize interactions between medical devices and arterial walls, as well as navigate through tissues and bones. This advanced simulation technology allows for unprecedented visibility during keyhole surgeries, facilitating rehearsal of surgical procedures and the selection of optimal approaches tailored to individual patients. By leveraging predictive computations, big data, and artificial intelligence, Oxford Heartbeat aims to enhance surgical preparation, ultimately leading to reduced complication rates, lower associated costs, and improved patient care. The company is actively conducting prospective clinical trials in NHS hospitals, supported by the UK government's AI in Health and Care Awards.

2Eyes Vision S.L, founded in 2015 and based in Madrid, Spain, specializes in developing and commercializing advanced technologies for visual diagnostics and corrections. The company emerged as a spin-off from CSIC and focuses on creating innovative solutions for presbyopia and cataract surgery. Its flagship product, SimVis Gekko, is a portable and adjustable visual simulator that allows patients to experience real-world vision prior to undergoing surgery. This device, which is FDA-cleared and CE-marked, assists ophthalmologists in selecting the most suitable intraocular lens for each patient, ultimately enhancing patient satisfaction and minimizing potential side effects. With the growing prevalence of presbyopia and cataracts, affecting over 2 billion people globally, 2Eyes Vision aims to address the challenges faced by both patients and clinicians in the ophthalmology field.

Onalabs develops remote, continuous and non-invasive bio-medical devices to monitor through the skin and sweat several vital signs and some biomarkers. Onalabs is the first non-invasive device able to measure some chemical parameters present in sweat using miniaturised biosensors. Its non-invasive products based on wearable formats empower the patients and their families to measure relevant vital signs and biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier management strategies, resulting in shorter hospital stays and prevention of unnecessary treatments. The solutions are addressed to chronic patients, such as COPD, HF and Diabetes.

Aelix Therapeutics SL is a biotechnology company based in Barcelona, Spain, focused on developing therapeutic vaccines and immunotherapies for HIV infection. Established in 2015 as a spin-off from the HIVACAT project, the company was founded by experts in the field, including Dr. Christian Brander and Bonaventura Clotet, who bring extensive experience in HIV research and biotech development. Aelix Therapeutics aims to leverage innovative immunogen designs to create vaccines that can elicit strong immune responses against HIV. By partnering with the HIVACAT consortium, the company has access to large cohorts of HIV-infected patients across multiple continents, enhancing its research capabilities and potential for impactful treatments. The company's work seeks to transform HIV treatment and pave the way for potential cures.

Rethink Medical is a medical company focused on developing innovative solutions to address various health challenges. The company aims to create new remedies and enhance existing medical technologies. Its initial product, the T-Control Urinary Catheter, exemplifies this mission by improving patient care and comfort in urinary management. Rethink Medical operates within the medical device sector, striving to deliver effective and user-friendly healthcare products.

AVX Pharma is a biopharmaceutical company dedicated to the development of innovative drugs aimed at addressing significant unmet medical needs in ophthalmology, particularly focusing on ocular surface diseases. Established in July 2013, the company originated from neurobiological research conducted by the Group on Ocular Sensory Innervation at the Instituto de Neurociencias de Alicante. With its operational base in Barcelona, AVX Pharma is committed to creating advanced medicinal products that facilitate faster recovery for patients suffering from conditions such as dry eye syndrome.

MetaHeps GmbH is a biotechnology company specializing in drug-induced liver injury (DILI) solutions for the pharmaceutical industry. It offers a unique service, creating personalized cell models from a small patient blood sample to reflect individual drug hepatotoxicity. MetaHeps serves research-driven pharmaceutical companies and global contract research organizations (CROs) during clinical drug development and post-marketing phases, aiding in the diagnosis or exclusion of DILI in patients. The company's mission is to enhance patient access to new drugs by innovatively addressing DILI challenges in drug development.

NUA Surgical is an award-winning startup based at the Innovation Hub in Galway, Ireland. The company has developed a patented surgical retractor designed to enhance the safety and efficiency of C-section procedures. NUA Surgical focuses on creating innovative medical devices for women's health, with a particular emphasis on improving outcomes for cesarean deliveries.